Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program

The Defense Health Agency (DHA) is issuing RFQ HT9402‑26‑Q‑9102 for Uniform Formulary (UF) Blanket Purchase Agreement (BPA) and Additional Discount Program (ADP) quotes on pharmaceutical agents identified by the DoD Pharmacy & Therapeutics Committee for inclusion on the UF, Basic Core Formulary (BCF) or Extended Core Formulary (ECF). Offerors must submit electronic quotes that are signed, complete, and include unit‑price detail to four decimal places for every strength, dosage form, and package size (e.g., 30, 100, 1000) identified by NDC. Prices must be equal to or lower than the company’s current Federal Supply Schedule (FSS), “Big 4,” and Joint National Contract (JNC) rates as verified on the VA NAC Search Tool, and must remain valid for 180 days. Quotes are contingent on the drug’s inclusion on the UF and may be further conditioned on the number of agents selected for BCF/ECF. Additional requirements include agreement to work with the DoD Prime Vendor Program for both MTF and mail‑order channels, and to open a limited distribution channel to Accredo for TRICARE mail‑order (DOD‑only). All submissions must follow the Manufacturer Quote Submission Checklist, include the company’s FSS contract number, and be sent to the RFQ point of contact by the quoted due date; termination of the agreement may be effected by either party with 120 days’ written notice.

Notice ID

b93bd479d1e543169eef990a974044d3

Solicitation Number

HT9402-26-Q-9102

NAICS Code

325412

Classification Code

6505